Quality improvement in neurology: Neuro-oncology quality measurement set
- PMID: 29500290
- PMCID: PMC10681057
- DOI: 10.1212/WNL.0000000000005251
Quality improvement in neurology: Neuro-oncology quality measurement set
Conflict of interest statement
J. Jordan reports no disclosures relevant to the manuscript. A. Sanders serves as a member of the National Quality Forum Palliative and End-of-Life Standing Committee. T. Armstrong reports no current conflicts; prior to October 30, 2016, served as consultant for AbbVie Pharmaceuticals, Tocagen, Pfizer, and Immunocellular Therapeutics, and received funding from Genentech and Merck. T. Asher, A. Bennett, and E. Dunbar report no disclosures relevant to the manuscript. N. Mohile has received consulting fees from Novocure. P. Nghiemphu, T. Smith, and D. Ney report no disclosures relevant to the manuscript. Go to
Figures
References
-
- Howlader N, Noone AM, Krapcho M, et al. . SEER Cancer Statistics Review, 1975–2013. Bethesda: National Cancer Institute. Available at: seer.cancer.gov/csr/1975_2013/. Accessed April 2016.
-
- Inskip PD, Tarone RE, Hatch EE, et al. . Sociodemographic indicators and risk of brain tumours. Int J Epidemiol 2003;32:225–233. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources